Lymphoma is a significant clinical entity because of its high incidence and complicated etiology and pathology. In this chapter, we discussed lymphoma in general and made focus in our previous studies in which we found unique features linking the interaction of EBV with sex steroid hormones in lymphoma cells. Sex steroid hormones included estrogen receptor and progesterone receptors that were investigated for their expression in malignant lymphoid cells. The localization of EBV in malignant lymphoid cells was also investigated. The two main types of lymphoma, Hodgkin Lymphoma, and non-Hodgkin lymphoma, were investigated for the interaction of EBV with sex steroid hormones. Unique features were obtained in terms of a bridge-linking estrogen receptor with EBV in Hodgkin lymphoma and progesterone receptor with EBV in non-Hodgkin lymphoma. The interactions between EBV and lymphoma are classic, but the reasons beyond this are not well established. The results of our studies highlighted new features by the existence of expressed sex steroid receptors. We think that the dissociation of combination between sex steroid hormones and EBV bears the link to design new therapeutic strategies for lymphoma.
Part of the book: Lymphoma
Parkinson’s Disease (PD) is the most prevalent neurodegenerative disease following Alzheimer’s disease. Its prevalence is increasing over time, and it is expected to reach a peak in 2030. The aim of the present study was to review the literature for various aspects of PD including general characteristics of the disease, its pathology, clinical features, therapeutic clinical trials, and animal models used to study PD. The results of this study showed that no curative therapy for PD has so far been developed. Altogether, PD is still a very hot area in medicine to be studied and to have new therapeutic options.
Part of the book: Parkinson’s Disease